RT Journal Article
SR Electronic
T1 A realistic way to investigate the design, and mechanical properties of flow diverter stents
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.23.21253935
DO 10.1101/2021.03.23.21253935
A1 Velvaluri, P.
A1 Pravdivtseva, M. S.
A1 Hensler, J.
A1 Wodarg, F.
A1 Jansen, O.
A1 Quandt, E.
A1 Hövener, J. B.
YR 2021
UL http://medrxiv.org/content/early/2021/03/26/2021.03.23.21253935.abstract
AB Purpose Braided flow diverters (FD) are highly sophisticated, delicate, and intricate mechanical devices used to treat intracranial aneurysms and thus saving lives. Testing such devices in vitro, however, remains an unsolved challenge. Here, we evaluate methods that access flow, design, and mechanical properties in vitro.Methods Flow properties, cell porosity, and cell area were evaluated by placing FDs in patient-derived, 3D printed models of human vasculature. 4D flow MRI was used to measure fluid dynamics. Laser microscopy was used to measure porosity and cell area with the top of aneurysm sac cut off for the model. New testing methods were developed to investigate the bending, circumferential, and longitudinal radial force continuously over varying diameters.Results The placement and flow properties of the FD in the vasculature models were successfully measured by MRI, although artifacts occurred. The setup to measure porosity and cell area inside of the model proved successful. The newly discussed methods allowed us to measure the indicated forces, to our knowledge for the first time, continuously.Conclusion Modern and specifically tailored techniques, some of which were presented here for the first time, allow detailed insights into the flow and mechanical properties of braided flow diverter stents.Competing Interest StatementFritz Wodarg: Personal fees from consultant activity for Microvention, personal fees from consultant activity for Acandis, personal fees from consultant activity for Cerus Endovascular, personal fees from consultant activity for Cerenovus outside the submitted work. Olav Jansen: Personal fees from consultant activity for STRYKER, personal fees from consultant activity for Medtronic, personal fees from consultant activity for Covidien, and personal fees for consultancy activity for Acandis outside the submitted work. Eckhard Quandt: Personal fees from Acquandas GmbH, Kiel, outside the submitted work.Funding StatementThis work was supported by the DFG from RTG "Materials4Brain" (GRK-2154); DFG under the cluster of excellence PMI 1267. Kiel University and the Medical Faculty are acknowledged for supporting the Molecular Imaging North Competence Center (MOIN CC) as a core facility for imaging in vivo. MOIN CC was founded by a grant from the European Regional Development Fund (ERDF) and the Zukunftsprogramm Wirtschaft of Schleswig-Holstein (Project no. 122-09-053). We are grateful to Phenox, Acandis, and Balt extrusion to provide the P64, DERIVO, and Silk endovascular devices.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Ethics Committee at the Faculty of Medicine, Kiel University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the lead author, PV, upon reasonable request.